Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(31 sites)

United States

Arizona Urology Specialists, Tuscon, Arizona

City of Hope - National Medical Center, Duarte, California

Urology Associates of Central California Medical Group, Fresno, California

Unio Health Partners - Genesis Research, LLC, San Diego, California

Colorado Urology, Lakewood, Colorado